478 related articles for article (PubMed ID: 29476617)
1. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
[TBL] [Abstract][Full Text] [Related]
2. Effect of β-blockers on 1-year survival and hospitalizations in patients with heart failure and atrial fibrillation: results from ESC-HF Pilot and ESC-HF Long-Term Registry.
Ozierański K; Kapłon-Cieślicka A; Balsam P; Tymińska A; Wancerz A; Peller M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
Pol Arch Intern Med; 2018 Nov; 128(11):649-657. PubMed ID: 30303491
[TBL] [Abstract][Full Text] [Related]
3. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
[TBL] [Abstract][Full Text] [Related]
4. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
5. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation.
Ahn MS; Yoo BS; Son JW; Park YJ; Lee HY; Jeon ES; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY; Kang DR; Go TH
J Korean Med Sci; 2021 Oct; 36(40):e252. PubMed ID: 34664798
[TBL] [Abstract][Full Text] [Related]
7. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
[TBL] [Abstract][Full Text] [Related]
8. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
9. Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction.
Zhou J; Cao J; Jin X; Zhou J; Chen Z; Xu D; Yang X; Dong W; Li L; Fan Y; Chen L; Zhong Q; Fu M; Hu K; Ge J;
ESC Heart Fail; 2020 Feb; 7(1):138-146. PubMed ID: 31994361
[TBL] [Abstract][Full Text] [Related]
10. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
[TBL] [Abstract][Full Text] [Related]
11. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
Barywani S; Petzold M
Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
[TBL] [Abstract][Full Text] [Related]
13. Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry.
Kapelios CJ; Lund LH; Benson L; Dahlström U; Rosano GMC; Hauptman PJ; Savarese G
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):756-767. PubMed ID: 34921603
[TBL] [Abstract][Full Text] [Related]
14. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
[TBL] [Abstract][Full Text] [Related]
15. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
Patel N; Ju C; Macon C; Thadani U; Schulte PJ; Hernandez AF; Bhatt DL; Butler J; Yancy CW; Fonarow GC
JACC Heart Fail; 2016 May; 4(5):348-56. PubMed ID: 26874392
[TBL] [Abstract][Full Text] [Related]
16. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
[TBL] [Abstract][Full Text] [Related]
18. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
[TBL] [Abstract][Full Text] [Related]
19. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy.
Georgiopoulou VV; Kalogeropoulos AP; Giamouzis G; Agha SA; Rashad MA; Waheed S; Laskar S; Smith AL; Butler J
Circ Heart Fail; 2009 Mar; 2(2):90-7. PubMed ID: 19808323
[TBL] [Abstract][Full Text] [Related]
20. Is foxglove effective in heart failure?
Chaggar PS; Shaw SM; Williams SG
Cardiovasc Ther; 2015 Aug; 33(4):236-41. PubMed ID: 25925484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
